Working Group – Gastroenterology

Date: Monday 24 September 2018
Time: 09:00 – 12:30

Chairs: Francesc Balagaur (Spain), Luigi Ricciardiello (Italy)

Time Session
09:00 – 09:20 Chemoprevention of hereditary GI cancers: state of the art – Luigi Ricciardiello (Italy)
09:20 – 09:40 How should we design the next chemopreventive trials – Evelein Dekker (The Netherlands)
09:40 – 10:00 Quality in endoscopy: does chromoendoscopy help in managing LS? – Francesc Balaguer (Spain)
10:00 – 11:00 Roundtable discussion of cases (on clinical/endoscopic management) – Andrew Latchford (UK)

Cases: Duodenal polyposis; serrated polyposis; juvenile polyposis

11:00 – 11:30 Coffee break
11:30 – 12:00 Hi-speed abstract presentations
(3 mins for presentation + 2 mins for questions)
Chairs: Evelein Dekker (The Netherlands), Andrew Latchford (UK)
11:30 – 11:35 N31: Identification of clinical, genetic and endoscopic predictors of incident colorectal cancer in Lynch syndrome – Ariadna Sanchez Garcia (Spain)
11:35 – 11:40 N80: An international study of duodenal disease in MAP: incidence of polyposis and cancer – Laura Thomas (UK)
11:40 – 11:45 N41: Small bowel neoplasia detection in Lynch syndrome using video capsule endoscopy – Raffaella Alessia Zuppardo (Italy)
11:45 – 11:50 N82: Endocuff-Assisted Colonoscopy versus standard colonoscopy in the surveillance of Serrated Polyposis Syndrome. A randomized, controlled and multicenter study – Liseth Rivero Sánchez (Spain)
11:50 – 11:55 N45: High-definition white-light colonoscopy versus chromoendoscopy for surveillance of lynch syndrome. A multicenter, randomized and controlled study (EndoLynch Study) – Liseth Rivero Sánchez (Spain)
11:55 – 12:00 N36 – Back to back comparison of colonoscopy with virtual chromoendoscopy using third generation narrow band imaging system to chromoendoscopy with indigo carmine in Lynch syndrome patients – Elia Samaha (France)
12:00 – 12:30 Collaborative studies
12:00 – 12:15 N02: Opportunities for collaboration: analysis of longitudinal data in Lynch syndrome carriers to inform development and calibration/validation of a new LS screening model – ‘Policy1-Lynch’ – Yoon-Jung Kang (Australia)
12:15 – 12:30 N03: Prevalence, phenotype and clinical consequences of mosaicism in APC and other colorectal cancer and polyposis associated genes – Manon Suerink (The Netherlands)
Top